GEN Exclusives

More »

GEN News Highlights

More »
Feb 12, 2007

GSK Settles Infringement Case with Watson for $35M

  • Watson Pharmaceuticals says that it reached a settlement with GlaxoSmithKline (GSK) on a patent litigation related to GSK’s antidepressant.

    In December 2005, Andrx, now owned by Watson, filed a lawsuit in the U.S. District Court for the Southern District of Florida against GSK alleging that the 150-mg dose of Wellbutrin XL infringed Andrx' patent.

    Under terms of the settlement, Andrx will receive a one-time payment of $35 million. GSK also received a royalty-bearing license to the relevant patent.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?